| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/02/2009 | CN101590044A Pharmacologic usage of berberine |
| 12/02/2009 | CN101590043A Compound preparation for treating respiratory tract infection and preparation method thereof |
| 12/02/2009 | CN101590042A Stable oral medicinal composition |
| 12/02/2009 | CN101590041A Pharmaceutical composition for relieving cough |
| 12/02/2009 | CN101590040A Composition containing indapamide and B vitamins as well as application thereof |
| 12/02/2009 | CN101590039A Composition containing indapamide and statins as well as application thereof |
| 12/02/2009 | CN101590038A Oral sustained release hypotensive composition |
| 12/02/2009 | CN101590037A Andrographolidume composition and application thereof |
| 12/02/2009 | CN101590036A Application of epoxydiene taken as inhibitor of proinflammatory mediators |
| 12/02/2009 | CN101590035A Application of dehydrogenated silybin in preparing anti-lung-cancer medicament |
| 12/02/2009 | CN101590034A Application of compound catechin in resisting drug-resistant strains |
| 12/02/2009 | CN101590033A Medicinal composition fat emulsion injection containing eucalyptol, limonene and alpha-pinene and preparation method |
| 12/02/2009 | CN101590032A Sustained-release tablet recipe for treating chest stasis obstruction symptom and preparation process thereof |
| 12/02/2009 | CN101590031A Disodium sulfodehydroabietate (DSDA) and composition and application thereof |
| 12/02/2009 | CN101590030A Pharmaceutical composition containing aliskiren, hydrochlorothiazide and folic acid and application thereof |
| 12/02/2009 | CN101590029A Propofol composition |
| 12/02/2009 | CN101590028A Tulobuterol-containing aquogel patch and preparation method thereof |
| 12/02/2009 | CN101590026A Method for preparing tiopronin enteric-coated tablet |
| 12/02/2009 | CN101590025A Simvastatin slow-release tablet and preparation method thereof |
| 12/02/2009 | CN101590024A Syringin preparation and preparation method thereof |
| 12/02/2009 | CN101590023A Clopidogrel hydrogen sulfate tablet and preparation method thereof |
| 12/02/2009 | CN101590022A Theophylline sodium glycinate slow-release tablet and preparation method thereof |
| 12/02/2009 | CN101590021A Cefuroxime axetil odor-masking pellet and preparation method |
| 12/02/2009 | CN101590020A Para-aminosalicylate colon positioning drug delivery system |
| 12/02/2009 | CN101590019A Soluble compound doxycycline hyclate powder for animals and preparation method thereof |
| 12/02/2009 | CN101590018A Etoposide solid lipid nanoparticle and preparation method thereof |
| 12/02/2009 | CN101590017A Method for preparing taxol magnetic nano liposome |
| 12/02/2009 | CN101590016A Ivermectin emulsion for injection and preparation method thereof |
| 12/02/2009 | CN101590015A Cationic adhesion type mycophenolate mofetil nano eye drop |
| 12/02/2009 | CN101590014A Process for preparing naloxone hydrochloride injection |
| 12/02/2009 | CN101590013A Compound injection suitable for foxes, raccoons and martens for expelling parasites |
| 12/02/2009 | CN101590012A Injection for treating paratyphoid of dogs and preparation method thereof |
| 12/02/2009 | CN101590010A Mycophenolate mofetil intraocular medicament releasing system |
| 12/02/2009 | CN101590009A Novel preparation of tilmicosin and salt of same for livestock and preparation method thereof |
| 12/02/2009 | CN101590008A Composition preparation of 24-methylene cycloartenol feruloyl esterase and purification process thereof |
| 12/02/2009 | CN101590007A Metformin hydrochloride/voglibose sugar-lowering oral preparation composition and preparation method thereof |
| 12/02/2009 | CN100564397C Low molecular weight heparin triethanolamine salt usable as local delivery antithrombotic treating agent, preparing process and use thereof |
| 12/02/2009 | CN100564391C Glycyrrhizic acid matrine salt and glycyrrhizic acid marine salt, its preparing method and use |
| 12/02/2009 | CN100564381C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 12/02/2009 | CN100564380C Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors |
| 12/02/2009 | CN100564378C Pyrrolidine oxadiazole- and thiadiazole derivatives |
| 12/02/2009 | CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof |
| 12/02/2009 | CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 12/02/2009 | CN100564365C Production of 1-[3,5-2(2,2-dimethyl) ethylcyano] benzyl triazole |
| 12/02/2009 | CN100564358C Method for making 4-(3,4-dichlorophenoxy)piperidine |
| 12/02/2009 | CN100564351C Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it |
| 12/02/2009 | CN100563716C Bio-compatible monodisperse nano polymer carrier and its preparation and medicine-carrying method |
| 12/02/2009 | CN100563715C Taxdol self-assembled precursor liposome and its preparation method |
| 12/02/2009 | CN100563714C Naloxone hydrochloride nano granule powder injection formulation and preparation thereof |
| 12/02/2009 | CN100563711C Slow-released anticancer injection |
| 12/02/2009 | CN100563710C Slow-released anticancer medicine preparation containing pyrimidine analog |
| 12/02/2009 | CN100563707C Activation and inhibition of the immune system |
| 12/02/2009 | CN100563692C Application of medication composition of containing magnet in preparing medicine for treating insufficiency of blood supply for brain |
| 12/02/2009 | CN100563688C Chinese medicine composition for treating drug addict and its suppository and application |
| 12/02/2009 | CN100563683C Externally applied formulation for treating skin amyloidosis |
| 12/02/2009 | CN100563676C External use traditional Chinese medicine tincture for treating psoriasis |
| 12/02/2009 | CN100563675C Safflower wine |
| 12/02/2009 | CN100563671C Fox immunity enhancer |
| 12/02/2009 | CN100563668C Ginseng preparation using vinegar and process thereof |
| 12/02/2009 | CN100563663C Externally used antifungal drug for treating skin fester infection |
| 12/02/2009 | CN100563662C Effective elements composition of Chinese traditional medicine for curing cardiovascular disease and the preparation method |
| 12/02/2009 | CN100563661C Medicine for treating gastrointestinal tract mucosal lesions and preparation method thereof |
| 12/02/2009 | CN100563660C Compounds for the normalization of the sleep/wake cycle |
| 12/02/2009 | CN100563659C Use of ferriporphyrin short peptide compound in preparation of medicament for resisting coronary heart disease |
| 12/02/2009 | CN100563658C Solid dispersoid or medicinal solid dispersoid preparation of phenylalanine derivative |
| 12/02/2009 | CN100563657C Enoxacin ocular sustained release gelata and preparation thereof |
| 12/02/2009 | CN100563656C Tamper-resistant oral opioid agonist |
| 12/02/2009 | CN100563655C Compositions for treating infection in cattle and swine and its uses |
| 12/02/2009 | CN100563654C Desloratadine dispersible tablet and its preparation method |
| 12/02/2009 | CN100563653C Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 12/02/2009 | CN100563652C Medicament for treating bacteria or virus infected disease of aquatic cultured animals |
| 12/02/2009 | CN100563651C 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 12/02/2009 | CN100563650C Indol-6 sulfonamide derivatives, their preparation and their use as 5-ht-6 modulators |
| 12/02/2009 | CN100563649C Chuanhuning lipid freeze-dry powder agent and preparing method thereof |
| 12/02/2009 | CN100563648C Composition for oral administration containing alkylene dioxybenzene derivative |
| 12/02/2009 | CN100563647C Medicine composition of erigeron breviscapus and tanshinone IIA sodium sulfoacid |
| 12/02/2009 | CN100563646C Oxaliplatinum liposome glucose formulation preparation method |
| 12/02/2009 | CN100563645C Beisalutin sustained-release implantation agent for curing entity tumour |
| 12/02/2009 | CN100563644C Carmustine sustained-release implantation agent for curing entity tumour |
| 12/02/2009 | CN100563643C Use of eNOS transcription enhancers in the cell therapy of ischemic heart diseases |
| 12/02/2009 | CN100563642C Chloromycetin eyedrops and preparation method thereof |
| 12/02/2009 | CN100563641C Composition of ambroxol, salt thereof and anti-infective drug |
| 12/02/2009 | CN100563638C Nifedipine controlled-releasing tablet and preparation method thereof |
| 12/02/2009 | CN100563636C Acemetacin sustained-release preparation and preparation method |
| 12/02/2009 | CN100563633C Hydrochloric acid diltiazem freeze-dried powder injection for injections and preparation method thereof |
| 12/02/2009 | CN100563632C Fleraxacin for injection and preparation method thereof |
| 12/02/2009 | CN100563628C Bendalysine eye gel preparation and its making method |
| 12/02/2009 | CN100563466C Beverages containing plant sterols |
| 12/01/2009 | US7626074 Method of screening candidate drugs for the treatment of leukemia |
| 12/01/2009 | US7626056 2,4-Dichloro-N-(4-cyclopropylmethanesulfonyl-1-cyclopropylmethylcyclohexyl-methyl) benzamide; glutamatergic neurotransmission dysfunction and diseases; dementia; antidepressants; learning enhancement; cognition activators; attention deficit disorders; autism; eating disorders; anxiolytic agents |
| 12/01/2009 | US7626055 2,4-diChloro-N-(4-cyclopropylmethanesulfonyl-1-cyclopropylmethylcyclohexyl-methyl) benzamide; glutamatergic neurotransmission dysfunction and diseases; dementia; antidepressants; learning enhancement; cognition activators; attention deficit disorders; autism; eating disorders; anxiolytic agents |
| 12/01/2009 | US7626054 Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 12/01/2009 | US7626044 Plant extracts comprising highly bioactive triptolide derivatives with low toxicity;(5-R)-5-hydroxytriptonide, (5R)-5-hydroxytriptolide, (5R)-5-hydroxy-14-epitriptolide. Delta 5,6-dehydrotriptonide, Delta 5,6-dehydrotriptolide; antiinflammatory agents; immunosuppressants; drug design |
| 12/01/2009 | US7626042 O-substituted hydroxyaryl derivatives |
| 12/01/2009 | US7626041 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment |
| 12/01/2009 | US7626039 and dual inhibitors of fXIa and plasma kallikrein; e.g. N ((S)-1-(4-(3-amino-1H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl)-2-phenylethyl)-3-phenylpropanamide; thromboembolic and inflammatory disorders |
| 12/01/2009 | US7626037 Thiazolidin-4-one derivatives |
| 12/01/2009 | US7626036 4-(3a-Methyl-1,3-dioxo-5-trifluoromethyl-3a,4-dihydro-3H-1l4-thia-2,6,6a-triaza-pentalen-2-yl)-2-trifluoromethyl-benzonitrile; anticarcinogenic agents; prostate glands; benign prostatic hyperplasia; alopecia; eating disorders; mammary glands; acne; AIDS; cachexia; male contraceptives; sexual disorders |
| 12/01/2009 | US7626032 4-Amino-3,3-dimethylpiperidine; reduced toxicity, and improved pharmacology and pharmacokinetics |
| 12/01/2009 | US7626031 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases |